PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hexyl methacrylate | 205-521-9 | 142-09-6 | - | - | - | - | 1 | - | - | - | - | Details |
| Bis(2-ethylhexyl) maleate | 205-524-5 | 142-16-5 | - | - | 2 | - | - | - | - | - | - | Details |
| 2,3-dihydroxypropyl laurate | 205-526-6 | 142-18-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Allyl heptanoate | 205-527-1 | 142-19-8 | - | - | 3 | - | 1 | - | - | - | - | Details |
| Diallyl 2,2'-oxydiethyl dicarbonate | 205-528-7 | 142-22-3 | - | - | 1 | - | - | - | - | - | - | Details |
| Cyclopentene | 205-532-9 | 142-29-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Sodium octyl sulphate | 205-535-5 | 142-31-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Sodium hydrogen glutamate | 205-538-1 | 142-47-2 | - | - | 3 | - | - | - | - | - | - | Details |
| N-(1-oxooctadecyl)sarcosine | 205-539-7 | 142-48-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperazine dihydrochloride | 205-551-2 | 142-64-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Tetrahydropyran | 205-552-8 | 142-68-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Heptane | 205-563-8 | 142-82-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Dipropylamine | 205-565-9 | 142-84-7 | - | - | 1 | - | - | - | - | - | - | Details |
| Sodium decyl sulphate | 205-568-5 | 142-87-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperazine adipate | 205-569-0 | 142-88-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Dodecyl methacrylate | 205-570-6 | 142-90-5 | - | - | 3 | - | 1 | 1 | - | - | - | Details |
| Isopropyl palmitate | 205-571-1 | 142-91-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Hexyl acetate | 205-572-7 | 142-92-7 | - | - | 2 | - | - | - | - | - | - | Details |
| Dibutyl ether | 205-575-3 | 142-96-1 | - | - | 1 | - | - | - | - | - | - | Details |
| Lauric acid | 205-582-1 | 143-07-7 | - | - | 2 | - | - | - | - | - | - | Details |
| Nonan-1-ol | 205-583-7 | 143-08-8 | - | - | 1 | - | - | - | - | - | - | Details |
| 2-(2-(2-butoxyethoxy)ethoxy)ethanol | 205-592-6 | 143-22-6 | - | - | 4 | - | 1 | - | - | - | - | Details |
| Bis(2-(2-methoxyethoxy)ethyl) ether | 205-594-7 | 143-24-8 | - | - | - | - | 1 | 1 | 1 | - | - | Details |
| (Z)-octadec-9-enol | 205-597-3 | 143-28-2 | - | - | 1 | - | - | - | - | - | - | Details |
| Bis(2-(2-butoxyethoxy)ethoxy)methane | 205-598-9 | 143-29-3 | - | - | 4 | - | - | - | - | - | - | Details |